WHO adds first mpox vaccine to prequalification list
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
Read MoreThe decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
Read MoreHealthcare agencies can submit their entries free of charge with a deadline of 30 April
Read MoreThe tool uses a series of connected algorithms that can assess if someone has PD from their nocturnal breathing
Read MoreIt is estimated that RSV infections in older adults account for 177,000 hospitalisations and 14,000 deaths each year in the US alone
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
